About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Careers
Case Studies
Events
Funding Calls
Other Technologies
Pages
People
Posts
Projects
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Ventures
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
Post
6 January 2021
Read more
: LifeArc funds COVID-19 drug screening hub at the University of Glasgow
Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
Post
2 April 2012
Read more
: Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
UK Drug Discovery Consortium symposium
Post
23 February 2009
Read more
: UK Drug Discovery Consortium symposium
MRC Technology welcomes launch of Knowledge Quarter
Post
4 December 2014
Read more
: MRC Technology welcomes launch of Knowledge Quarter
MSD joins £4.5 million Dementia Consortium
Post
8 March 2016
Read more
: MSD joins £4.5 million Dementia Consortium
How we will use your data
Page
8 July 2024
Read more
: How we will use your data
LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
Post
31 January 2024
Read more
: LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
Reporting and whistleblowing information
Publication
9 April 2024
Read more
: Reporting and whistleblowing information
PACE: Pathways to Antimicrobial Clinical Efficacy
Funding Call
26 March 2024
Read more
: PACE: Pathways to Antimicrobial Clinical Efficacy
Dementia Consortium signs new pharma partner Astex Pharmaceuticals
Post
12 October 2015
Read more
: Dementia Consortium signs new pharma partner Astex Pharmaceuticals
Dementia Consortium funds project focusing on ALS and FTLD
Post
14 September 2015
Read more
: Dementia Consortium funds project focusing on ALS and FTLD
Repurposing therapies for EB
Funding Call
25 March 2024
Read more
: Repurposing therapies for EB
Previous Page
1
…
3
4
5
6
7
…
10
Next Page
Close Modal
